858 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Bronchogenic"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
2 Recruiting Feasibility of the Research for Mutation of K-ras and EGFR in CTCs From Metastatic Non Small Cells Bronchial Carcinomas
Condition: Non-small Cell Lung Cancer Metastatic
Intervention: Biological: CTC
3 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
4 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
5 Recruiting Integrated Molecular Profiling in Advanced Cancers Trial
Conditions: Breast Cancer;   Non-small Cell Lung Cancer;   Colorectal Cancer;   Genitourinary Cancer;   Pancreatobiliary Gastrointestinal Cancer;   Upper Aerodigestive Tract Cancer;   Gynecological Cancers
Intervention:
6 Recruiting Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
Conditions: Non-small Cell Lung Cancer Metastatic;   Small Cell Lung Carcinoma
Intervention: Other: therapeutic interventions
7 Unknown  Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer
Condition: Small Cell Carcinoma of Lung
Intervention: Drug: Irinotecan
8 Recruiting Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Everolimus;   Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Bevacizumab
9 Recruiting PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Bronchoalveolar Cell Lung Cancer;   Large Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: PI3K inhibitor BKM120;   Drug: pemetrexed disodium;   Drug: carboplatin;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: quality-of-life assessment
10 Recruiting AUY922 for Advanced ALK-positive NSCLC
Condition: Non Small Cell Lung Cancer
Intervention: Drug: AUY922
11 Recruiting Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation
Condition: Non-small-cell Lung Cancer
Interventions: Drug: 1-year treatment with icotinib;   Drug: 2-year treatment with icotinib
12 Recruiting Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)
Condition: Non-Small Cell Lung Cancer
Interventions: Radiation: Peripherally located lung tumor;   Radiation: Centrally located lung tumor
13 Recruiting Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer Metastatic
Intervention: Drug: Erlotinib
14 Recruiting Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)
Conditions: Chemotherapeutic Agent Toxicity;   Lung Cancer
Interventions: Drug: Carboplatin;   Drug: Docetaxel;   Drug: Anvirzel;   Behavioral: Questionnaires
15 Recruiting A Study Of Crizotinib Versus Chemotherapy In Previously Untreated ALK Positive East Asian Non-Small Cell Lung Cancer Patients
Condition: NSCLC (Non-small Cell Lung Cancer)
Interventions: Drug: Crizotinib;   Drug: Pemetrexed/Cisplatin;   Drug: Pemetrexed/Carboplatin
16 Recruiting Icotinib Treat the Patient With Brain Metastasis Epidermal Growth Factor Receptor(EGFR) Mutant Non Small Cell Lung Cancer Comparing With Whole Brain Radiotherapy
Conditions: Brain Metastasis;   Non Small Cell Lung Cancer
Interventions: Radiation: whole brain radiation(WBI);   Drug: Icotinib
17 Recruiting TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)
Condition: Non-small Cell Lung Cancer
Intervention: Other: No intervention
18 Recruiting Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Biological: HLA-A*0201restricted URLC10 peptides with adjuvant
19 Not yet recruiting Safety and Efficacy Study of CO-1686 or Erlotinib in Patients With EGFR Mutant NSCLC Who Have Not Had Any Previous EGFR Directed Therapy
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: CO-1686 Mono-Therapy;   Drug: Erlotinib Mono-Therapy
20 Recruiting Detection of Genetic Markers of Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Procedure: Biopsy of the major carinal area;   Procedure: Biopsy of abnormal & suspicious areas of the bronchial tree;   Procedure: Evaluation of the tumor for DNA mutations;   Procedure: Bronchoalveolar Lavage (BAL) for cytokine analysis;   Procedure: Correlation of flow cytometric & RT PCR for TNM stage;   Procedure: Analysis of lymph nodes

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years